Sickle cell anemia

Abstract:
Sickle cell anemia belongs to the hemoglobinopathies. A gene defect leads to the formation of an abnormal b-chain, the so-called hemoglobin S. Deoxygenated HbS tends to aggregate in long polymers to form crystals. This causes the erythrocytes to lose their deformability and to take on the sickle form. These erythrocytes become sequestrated in the reticulo-endotheliomal system (extra-vascular hemolysis) or may lead to occlusions in small vessels (infarctions). Sickle cell anemia occurs most commonly in people from sub-Saharan Africa and the Caribbean. It offers a certain protection from malaria. The fact that absence of oxygen leads to the sickling of erythrocytes, is used in the laboratory for the sickle cell test. The definitive diagnosis is determined by means of hemoglobin electrophoresis.

Clinical picture:
Sickle cell anemia
is the homozygous form. The heterozygous form is called sickle cell-trait. In spite of hemoglobin concentration between 60 and 100 g/L, there are few symptoms of anemia, due to the early disassociation of oxygen in the HbS. Sickle cell crises are characteristic of sickle cell anemia. These entail acute, painful, episodes caused by vascular occlusions. They are usually brought on by infections or exposure to the cold. All organs can be affected by these vascular occlusions. Normally, this results in different growth lengths of fingers and toes. Cholelithiasis occurs often as a result of chronic hemolysis. Similar to spherocytosis, infections by parvovirus B19 can lead to aplastic crises.

Hematology:
In the blood film, the characteristic sickle cells as well as target cells can be found. In adults, functional asplenia is often present due to the recurrent splenic infarctions. Howell-Jolly-bodies and Pappenheimer bodies can be seen.


Table of Contents